Difference between revisions of "ICRP Glossary"
Jump to navigation
Jump to search
| Line 468: | Line 468: | ||
*[[Granulocyte-macrophage colony-stimulating factor]] | *[[Granulocyte-macrophage colony-stimulating factor]] | ||
| − | *[[Gray]] | + | *[[Gray]] (Gy) |
*[[Growth fraction]] | *[[Growth fraction]] | ||
| Line 919: | Line 919: | ||
=== <big><span id="S">S</span></big> === | === <big><span id="S">S</span></big> === | ||
| + | |||
| + | *[[S coefficient (radiation weighted)]] S<sub>W</sub>[(r<sub>T</sub>←r<sub>s</sub>)] | ||
| + | |||
| + | * SAF (see [[Specific absorbed fraction]]) | ||
*[[Safety case]] | *[[Safety case]] | ||
| Line 925: | Line 929: | ||
*[[Scintigraphy]] | *[[Scintigraphy]] | ||
| + | |||
| + | *SEE (see [[Specific effective energy]]] | ||
*[[Self-help protection]] | *[[Self-help protection]] | ||
| Line 931: | Line 937: | ||
*[[Severe deterministic injury]] | *[[Severe deterministic injury]] | ||
| + | |||
| + | *[[Sievert]] (Sv) | ||
*SLDR (see [[Sublethal damage repair]]) | *SLDR (see [[Sublethal damage repair]]) | ||
| Line 947: | Line 955: | ||
*Source (see [[Radiation source]]) | *Source (see [[Radiation source]]) | ||
| + | |||
| + | *[[Source region]] | ||
*[[Source term]] | *[[Source term]] | ||
| Line 955: | Line 965: | ||
*[[Special (non-routine) monitoring]] | *[[Special (non-routine) monitoring]] | ||
| + | |||
| + | *[[Specific absorbed fraction]] | ||
| + | |||
| + | *[[Specific effective energy]] | ||
| + | |||
| + | *[[Spongiosa]] | ||
*[[Spontaneous fission]] | *[[Spontaneous fission]] | ||
| Line 988: | Line 1,004: | ||
*[[Telangiectasia]] | *[[Telangiectasia]] | ||
| + | |||
| + | *[[Thermodynamic diameter]] | ||
| + | |||
| + | *[[Thoracic airways]] | ||
*[[Threshold dose for tissue reactions]] | *[[Threshold dose for tissue reactions]] | ||
| + | |||
| + | *[[Threshold levels]] | ||
*[[Tissue absorbed dose]] (see [[Organ/tissue absorbed dose]]) | *[[Tissue absorbed dose]] (see [[Organ/tissue absorbed dose]]) | ||
| Line 1,030: | Line 1,052: | ||
=== <big><span id="U">U</span></big> === | === <big><span id="U">U</span></big> === | ||
| + | |||
| + | *[[Unattached fraction]] | ||
*[[Unsealed source]] | *[[Unsealed source]] | ||
| + | |||
| + | *[[Uptake]] | ||
*[[Utilitarian ethics]] | *[[Utilitarian ethics]] | ||
| Line 1,042: | Line 1,068: | ||
*[[Virtue ethics]] | *[[Virtue ethics]] | ||
| + | |||
| + | *[[Voxel phantom]] | ||
=== <big><span id="W">W</span></big> === | === <big><span id="W">W</span></big> === | ||
Revision as of 15:05, 28 March 2021
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. Some entries include historical descriptions to help readers better understand the term in a particular context.
It is a living document, updated regularly.
Many ICRP publications feature their own glossaries including, for example, highly specialized terms relevant to that specific publication or helpful for a reader to have close at hand, or when introducing new terms to be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ... |
A
- Acute radiation sickness (see Acute radiation syndrome)
- ALI (see Annual limit on intake)
- AMAD (see Activity median aerodynamic diameter)
- Ambient dose equivalent, H*(10)
- ARS (see Acute radiation syndrome)
B
- BAT (see Best available techniques)
C
D
- DAC (see Derived air concentration)
- DD (see Doubling dose)
- DIL (see Derived investigation level)
- DDREF (see Dose and dose-rate effectiveness factor)
- Directional dose equivalent H’(d,Ω)
- Dose (of ionising radiation)
E
- EAR (see Excess absolute risk)
- ELR (i.e. Excess Lifetime Risk, see Lifetime risk estimates)
- Endosteal tissue (see Endosteum)
- ERR (see Excess relative risk)
- Excess lifetime risk (see Lifetime risk estimates)
F
- Fluence, Φ
G
- Gray (Gy)
H
- HATM (see Human Alimentary Tract Model]
I
- Incidence rate (see Incidence)
J
K
- Kerma, K
L
- LET (see *Linear energy transfer)
- LLE (see Lifetime risk estimates)
- Loss of Life Expectancy (see Lifetime risk estimates)
- LSS (see Life Span Study)
M
- MMD (see *Mass median diameter)
N
- NHEJ (see Non-homologous end joining)
O
P
- Particle fluence (see Fluence)
- Personal dose equivalent, Hp(d)
- PLDR (see Potentially lethal damage repair)
Q
- Quality factor, Q(L)
R
- Radiation detriment (see Detriment)
- RAP (see Reference Animal and Plant)
- RBE (see Relative biological effectiveness)
- Reference female (see Reference Individual)
- Reference male (see Reference Individual)
- REID (see Lifetime risk estimates)
- Response function (see Dose-response function)
- Risk of exposure-induced death (see (see Lifetime risk estimates)
- ROS (see Reactive oxygen species)
- RR (see Relative risk)
S
- S coefficient (radiation weighted) SW[(rT←rs)]
- SAF (see Specific absorbed fraction)
- SEE (see Specific effective energy]
- Sievert (Sv)
- SLDR (see Sublethal damage repair)
- Source (see Radiation source)
T
- Transport of risk (see Transfer of risk)
U
V
W
- wT (see Tissue weighting factor)
- wR (see Radiation weighting factor)
X
Y
Z
...
- α/β ratio (see α/β value)
